RxDoctor Payments Data

Justin Santarelli, MD

Neurological Surgery · Valhalla, NYNPI 1528226792

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.8%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 37.1% of the total. Reporting peaked in 2019 at $3,037 and has fallen 88.1% since, to $361 in 2025.

$8,564in general payments, 2019–2025

Across 164 payments — averaging $52.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Penumbra, Inc.$2K
  • Medical Device Business Services, Inc.$1K
  • Microvention, Inc.$1K
  • Phenox Inc.$546
  • Stryker$255
  • plus $480 from 6 others
$155,972in research payments, 2019–2025

Across 16 payments — averaging $9748.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$156K

What the payments were for

  • Travel & lodging$4,52553%
  • Food & beverage$4,03547%
  • Gifts$40%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,564 in reported general payments places this provider in the 65th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York

Medicare billing

Part B allowed, 2024
$92,185
Medicare patients
78
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Valhalla

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →